HOMOSALATE
Cette fiche confirme une dénomination commune officielle d’ingrédient pour l’étiquetage des produits cosmétiques de l’UE. Elle ne confirme pas à elle seule que la substance est autorisée, non restreinte ou sûre.
Aperçu des preuves mondiales
L’identité résolue présente des preuves réglementaires correspondantes dans 5 des 13 jeux de données de marchés indexés : 4 fiches de pays et 1 fiches d’annexes de l’UE. Chaque résultat et chaque lacune de preuves sont énumérés ci-dessous.
Identité résolue de la substance
Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester
Note de restriction de l’inventaire : VI/3
7 noms correspondants ou signalés
Preuves réglementaires dans les 13 marchés
Ouvrez chaque fiche correspondante pour connaître son champ d’application, sa concentration, ses conditions, ses avertissements et la version de la source officielle.
Balayez ou faites défiler horizontalement pour voir la couverture des jeux de données et les actions suivantes.
| Marché | Résultat | Fiches | Jeu de données | Signification / action suivante |
|---|---|---|---|---|
| European Union EU | Correspondance de liste positive conditionnelle | 1Ouvrir la fiche 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| Great Britain GB | Permitted list with conditions | 1Ouvrir la fiche 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| Canada CA | Aucune correspondance trouvée | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Permitted list with conditions | 1Ouvrir la fiche 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| ASEAN ASEAN | Permitted list with conditions | 1Ouvrir la fiche 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| China CN | Aucune correspondance trouvée | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Aucune correspondance trouvée | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1Ouvrir la fiche 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| United States US | Aucune correspondance trouvée | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | Aucune correspondance trouvée | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Aucune correspondance trouvée | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Aucune correspondance trouvée | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | Aucune correspondance trouvée | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
Fiches de marché correspondantes et conditions
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026Preuves exactes des annexes II à VI
HOMOSALATE
Champ d’application du produit : Face products with the exception of propellent spray products
Concentration maximale : 7,34 %
Restrictions : From 1 January 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 July 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
Identité et propriétés chimiques

Homosalate
2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester is a member of phenols and a benzoate ester. It is functionally related to a salicylic acid. — ChEBI
- Nom IUPAC
- (3,3,5-trimethylcyclohexyl) 2-hydroxybenzoate
- Formule moléculaire
- C16H22O3
- Masse moléculaire
- 262.34 g/mol
- Masse exacte
- 262.15689456 Da
- XLogP3
- 5,0
- Surface polaire topologique
- 46,5 Ų
- Donneurs de liaisons hydrogène
- 1
- Accepteurs de liaisons hydrogène
- 3
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:91642
- ChEMBL:CHEMBL1377575
- EPA DTXSID:DTXSID1026241
- PubMed:39159849
- PubMed:38381479
- PubMed:28551711
- PubMed:24004914
- PubMed:23769903
- PubMed:23062433
- PubMed:22884209
- PubMed:22749456
- PubMed:22669305
- PubMed:22612478
- PubMed:22214440
- PubMed:21872075
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 322 to 329 °F at 760 mmHg (NTP, 1992) Source: CAMEO Chemicals
- Density: 1.045 at 77 °F (NTP, 1992) - Denser than water; will sink Source: CAMEO Chemicals
- Flash Point: greater than 200 °F (NTP, 1992) Source: CAMEO Chemicals
- Physical Description: 3,3,5-trimethylcyclohexylsalicylate appears as viscous or light yellow to slightly tan liquid or oil. (NTP, 1992) Source: CAMEO Chemicals
- Solubility: Insoluble (<1 mg/ml at 79 °F) (NTP, 1992) Source: CAMEO Chemicals
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
- Note: This chemical does not meet GHS hazard criteria for 67% (152 of 227) of all reports. Source: European Chemicals Agency (ECHA)
- Signal: Warning Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (16.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (16.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (16.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361d (11.5%): Suspected of damaging the unborn child [Warning Reproductive toxicity]; H410 (11.5%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 227 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 152 of 227 reports by companies.; There are 3 notifications provided by 75 of 227 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Industry Uses: Not Known or Reasonably Ascertainable Source: EPA Chemical Data Reporting (CDR)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Recherche complémentaire sur la substance auprès de sources faisant autorité
Chaque lien lance une recherche de cette identité dans la source concernée. Un lien est une piste de recherche, et non l’affirmation que la source détient une fiche exacte. Ce qu’est chaque source et sa valeur juridique
Aller plus loin avec cette fiche
Source officielle et champ d’application
Importé de la décision d’exécution (UE) 2025/1175 de la Commission (version du jeu de données EU 2025/1175). Le glossaire fournit les dénominations communes des ingrédients pour la liste d’ingrédients exigée par l’article 19, paragraphe 1, point g) ; ce n’est ni une liste d’autorisation ni une liste de sécurité.
Ouvrir la décision officielle